Table 3.
Incidence of post-partum hemorrhage by severity of blood loss and receipt of AMTSL components (N = 39184)
n | Blood loss ≥ 500 mL | Blood loss ≥ 700 mL | |
---|---|---|---|
No oxytocin prophylaxis |
|
n = 932 |
n = 638 |
No AMTSL components |
1832 |
302 (16.5) |
154 (8.4) |
UM only |
959 |
219 (22.8) |
93 (9.7) |
CCT only |
4014 |
204 (5.1) |
196 (4.9) |
UM + CCT |
1416 |
207 (14.6) |
195 (13.8) |
Oxytocin prophylaxis |
|
n = 1740 |
n = 807 |
Intramuscular administration |
|||
Oxytocin only |
2853 |
560 (19.6) |
109 (3.8) |
Oxytocin + CCT |
6103 |
147 (2.4) |
90 (1.5) |
Oxytocin + CCT + UM |
4085 |
223 (5.5) |
110 (2.7) |
Intravenous administration |
|||
Oxytocin only |
785 |
99 (12.6) |
8 (1.0) |
Oxytocin + CCT |
794 |
58 (7.3) |
9 (1.1) |
Oxytocin + CCT + UM | 16343 | 653 (4.0) | 481 (2.9) |
Data are n (%). AMTSL denotes active management of the third stage of labor; CCT, controlled cord traction; UM, uterine massage; and PPH, post-partum hemorrhage.